Adverum Biotechnologies(us:ADVM)
3.86
-2.03%
Updated on 2025-04-04
Open:3.79
Close:3.86
High:4.01
Low:3.76
Prev Close:3.94
Volume:142272.00
Turnover:546819.06
Turnover Ratio:0.68%
Shares:20.80M
MarketCap:80.30M
| Date | Total | Total Shares | Total Ratio | New | Increased | Decreased |
|---|---|---|---|---|---|---|
| 2024-06-30 | 79 | 17852335 | 85.82% | 19 | 24 | 26 |
| 2024-03-31 | 82 | 16754559 | 80.55% | 22 | 20 | 36 |
| 2023-12-31 | 71 | 6513510 | 6.42% | 11 | 13 | 25 |
| 2023-09-30 | 69 | 65258335 | 64.59% | 10 | 15 | 28 |
| 2023-06-30 | 63 | 65656238 | 65.01% | 8 | 12 | 29 |
| 2023-03-31 | 64 | 62722791 | 62.37% | 5 | 14 | 27 |
| 2022-12-31 | 82 | 57303200 | 57.24% | 7 | 14 | 46 |
| 2022-09-30 | 90 | 58521534 | 58.68% | 16 | 11 | 41 |
| date | orgName | total | ratio | changeShares | changeRatio |
|---|---|---|---|---|---|
| 2024-03-31 | Tcg Crossover Management, Llc | 2008340 | 9.66% | 2008340 | |
| 2024-03-31 | Vr Adviser, Llc | 1556419 | 7.48% | 1041664 | 202.36% |
| 2024-03-31 | Vivo Capital, Llc | 1500000 | 7.21% | 1500000 | |
| 2024-03-31 | Logos Global Management Lp | 1499999 | 7.21% | 1499999 | |
| 2024-03-31 | Frazier Life Sciences Management, L.P. | 1069244 | 5.14% | 1069244 | |
| 2024-03-31 | Vanguard Group Inc | 907151 | 4.36% | 488248 | 116.55% |
| 2024-03-31 | Fmr Llc | 900527 | 4.33% | 288100 | 47.04% |
| 2024-03-31 | Bml Capital Management, Llc | 833117 | 4.01% | 377692 | 82.93% |
| 2024-03-31 | Franklin Resources Inc | 675675 | 3.25% | 675675 | |
| 2024-03-31 | Commodore Capital Lp | 657333 | 3.16% | -342667 | -34.27% |
About
Adverum Biotechnologies, Inc. is a clinical-stage gene therapy company that engages in the development of gene therapies for ocular and rare diseases. The company was founded by Mark S. Blumenkranz, Thomas W. Chalberg, Jr., Mitchell H. Finer, and Steven Daniel Schwartz on July 17, 2006 and is headquartered in Redwood City, CA.
Address:100 Cardinal Way
Website:http://www.adverum.com
Market Movers